Turning Point Therapeutics, Inc. Comprehensive Income
Turning Point Therapeutics, Inc. reported Comprehensive Income of -$124.61 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-08-08
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$124.61M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-03-31 was -$78.56M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was -$79.71M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$66.34M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$238.03M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$157.35M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$71.86M.
- Turning Point Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$24.79M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$124.61M 10-Q · filed 2022-08-08 | -$203.17M 10-Q · filed 2022-08-08 | -$282.88M derived: sum of 3 quarters · filed 2022-08-08 | -$349.22M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | -$78.56M 10-Q · filed 2022-05-10 | -$158.27M derived: sum of 2 quarters · filed 2022-05-10 | -$224.61M derived: sum of 3 quarters · filed 2022-05-10 | -$280.91M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-12-31 | -$79.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$146.05M derived: sum of 2 quarters · filed 2022-02-28 | -$202.34M derived: sum of 3 quarters · filed 2022-08-08 | -$238.03M 10-K · filed 2022-02-28 |
| 2021-09-30 | -$66.34M 10-Q · filed 2021-11-09 | -$122.64M derived: sum of 2 quarters · filed 2022-08-08 | -$158.33M 10-Q · filed 2021-11-09 | -$205.91M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | -$56.30M 10-Q · filed 2022-08-08 | -$91.98M 10-Q · filed 2022-08-08 | -$139.56M derived: sum of 3 quarters · filed 2022-08-08 | -$157.88M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$35.69M 10-Q · filed 2022-05-10 | -$83.27M derived: sum of 2 quarters · filed 2022-05-10 | -$101.58M derived: sum of 3 quarters · filed 2022-05-10 | -$132.01M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$47.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$65.89M derived: sum of 2 quarters · filed 2022-02-28 | -$96.32M derived: sum of 3 quarters · filed 2022-02-28 | -$157.35M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$18.31M 10-Q · filed 2021-11-09 | -$48.74M derived: sum of 2 quarters · filed 2021-11-09 | -$109.78M 10-Q · filed 2021-11-09 | -$130.78M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$30.43M 10-Q · filed 2021-08-09 | -$91.46M 10-Q · filed 2021-08-09 | -$112.47M derived: sum of 3 quarters · filed 2022-02-28 | -$132.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$61.03M 10-Q · filed 2021-05-05 | -$82.04M derived: sum of 2 quarters · filed 2022-02-28 | -$102.55M derived: sum of 3 quarters · filed 2022-02-28 | -$119.35M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$21.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$41.52M derived: sum of 2 quarters · filed 2022-02-28 | -$58.31M derived: sum of 3 quarters · filed 2022-02-28 | -$71.86M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$20.51M 10-Q · filed 2020-11-12 | -$37.30M derived: sum of 2 quarters · filed 2020-11-12 | -$50.85M 10-Q · filed 2020-11-12 | -$59.87M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$16.80M 10-Q · filed 2020-08-10 | -$30.34M 10-Q · filed 2020-08-10 | -$39.36M derived: sum of 3 quarters · filed 2021-03-01 | -$45.36M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$13.55M 10-Q · filed 2020-05-12 | -$22.57M derived: sum of 2 quarters · filed 2021-03-01 | -$28.56M derived: sum of 3 quarters · filed 2021-03-01 | -$33.60M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$15.02M derived: sum of 2 quarters · filed 2021-03-01 | -$20.05M derived: sum of 3 quarters · filed 2021-03-01 | -$24.79M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$6.00M 10-Q · filed 2019-11-04 | -$11.03M derived: sum of 2 quarters · filed 2019-11-04 | -$15.77M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$5.04M 10-Q · filed 2019-08-06 | -$9.77M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$4.73M 10-Q · filed 2019-05-31 | |||
| 2017-12-31 | -$16.59M 10-K · filed 2020-03-18 |